Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project.
Gallacher J, de Reydet de Vulpillieres F, Amzal B, Angehrn Z, Bexelius C, Bintener C, Bouvy JC, Campo L, Diaz C, Georges J, Gray A, Hottgenroth A, Jonsson P, Mittelstadt B, Potashman MH, Reed C, Sudlow C, Thompson R, Tockhorn-Heidenreich A, Turner A, van der Lei J, Visser PJ; ROADMAP Consortium. Gallacher J, et al. Among authors: amzal b. J Alzheimers Dis. 2019;67(2):495-501. doi: 10.3233/JAD-180370. J Alzheimers Dis. 2019. PMID: 30584137 Free PMC article.
Artificial Intelligence and Machine Learning Applied at the Point of Care.
Angehrn Z, Haldna L, Zandvliet AS, Gil Berglund E, Zeeuw J, Amzal B, Cheung SYA, Polasek TM, Pfister M, Kerbusch T, Heckman NM. Angehrn Z, et al. Among authors: amzal b. Front Pharmacol. 2020 Jun 18;11:759. doi: 10.3389/fphar.2020.00759. eCollection 2020. Front Pharmacol. 2020. PMID: 32625083 Free PMC article. Review.
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, Hobbiger SF, Hockley KS, Luciani D, Phillips LD, Quartey G, Sarac SB, Stoeckert I, Tzoulaki I, Micaleff A, Ashby D; IMI-PROTECT benefit-risk participants. Mt-Isa S, et al. Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):667-78. doi: 10.1002/pds.3636. Epub 2014 May 13. Pharmacoepidemiol Drug Saf. 2014. PMID: 24821575 Review.
Rivastigmine exposure provided by a transdermal patch versus capsules.
Mercier F, Lefèvre G, Huang HL, Schmidli H, Amzal B, Appel-Dingemanse S. Mercier F, et al. Among authors: amzal b. Curr Med Res Opin. 2007 Dec;23(12):3199-204. doi: 10.1185/030079908X253438. Curr Med Res Opin. 2007. PMID: 18001519 Clinical Trial.
36 results